Announcement on Voluntary Disclosure on the Acceptance of New Drug Application for Silevimig Injection

About this update from Chongqing Genrix Biopharmaceutical Co., Ltd. Class A

Announcement on Voluntary Disclosure on the the Acceptance of New Drug Application for Silevimig Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Chongqing Genrix Biopharmaceutical Co., Ltd. Class A